A National Multicenter Evaluation of the Clinical Utility of Optical Genome Mapping for Assessment of Genomic Aberrations in Acute Myeloid Leukemia
Brynn Levy, Linda Banovic Baughn, Scott Chartrand, Brandon LaBarge, David F. Claxton, Alan Lennon, Yassmine M. N. Akkari, Claudia P. Cujar, Ravindra B Kolhe, Kate Kroeger, Beth A. Pitel, Nikhil Sahajpal, Malini Sathanoori, George Vlad, Lijun Zhang, , James Riley Broach
This study evaluates optical genome mapping (OGM) for detecting genomic aberrations in AML, finding it identifies all clinically relevant SVs and CNVs and detects additional variants missed by standard methods.
medRxiv · Nov 7, 2020 · PreprintGenetic & Genomic Medicine